FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W268446039> ?p ?o ?g. }

• W268446039 endingPage "5002" @default.
• W268446039 startingPage "4989" @default.
• W268446039 abstract "This study aimed to determine the effect of mangiferin on the cell cycle in HL-60 leukemia cells and expression of the cell cycle-regulatory genes Wee1, Chk1 and CDC25C and to further investigate the molecular mechanisms of the antileukemic action of mangiferin. The inhibitory effect of mangiferin on HL-60 leukemia cell proliferation was determined by the MTT assay. The impact of mangiferin on the HL-60 cell cycle was evaluated by flow cytometry. After the cells were treated with different concentrations of mangiferin, the expression levels of Wee1, Chk1 and CDC25C mRNA were determined by RT-PCR, and Western blot was used to evaluate the expression levels of cdc25c, cyclin B1, and Akt proteins. The inhibition of HL-60 cell growth by mangiferin was dose- and time-dependent. After treatment for 24 h, cells in G2/M phase increased, and G2/M phase arrest appeared with increased mRNA expression of Wee1, Chk1 and CDC25C. Mangiferin inhibited Chk1 and cdc25c mRNA expression at high concentrations and induced Wee1 mRNA expression in a dose-dependent manner. It significantly inhibited ATR, Chk1, Wee1, Akt, and ERK1/2 phosphorylation but increased cdc2 and cyclin B1 phosphorylation. Furthermore, mangiferin reduced cdc25c, cyclin B1, and Akt protein levels while inducing Wee1 protein expression. It also antagonized the phosphorylation effect of vanadate on ATR, and the phosphorylation effect of EGF on Wee1. These findings indicated that mangiferin inhibits cell cycle progression through the ATR-Chk1 stress response DNA damage pathway, leading to cell cycle arrest at G2/M phase in leukemia cells." @default.
• W268446039 created "2016-06-24" @default.
• W268446039 creator A5006466643 @default.
• W268446039 creator A5024325354 @default.
• W268446039 creator A5032098174 @default.
• W268446039 creator A5040831062 @default.
• W268446039 creator A5061528583 @default.
• W268446039 date "2015-01-01" @default.
• W268446039 modified "2023-09-29" @default.
• W268446039 title "Mangiferin induces cell cycle arrest at G2/M phase through ATR-Chk1 pathway in HL-60 leukemia cells" @default.
• W268446039 cites W1524628399 @default.
• W268446039 cites W1541540076 @default.
• W268446039 cites W1614427627 @default.
• W268446039 cites W1962995704 @default.
• W268446039 cites W1967630574 @default.
• W268446039 cites W1987703797 @default.
• W268446039 cites W1996293435 @default.
• W268446039 cites W1999022874 @default.
• W268446039 cites W2001123346 @default.
• W268446039 cites W2002796620 @default.
• W268446039 cites W2017229935 @default.
• W268446039 cites W2028641698 @default.
• W268446039 cites W2029555805 @default.
• W268446039 cites W2031986590 @default.
• W268446039 cites W2040328392 @default.
• W268446039 cites W2047057122 @default.
• W268446039 cites W2048585633 @default.
• W268446039 cites W2052034970 @default.
• W268446039 cites W2062219923 @default.
• W268446039 cites W2063180072 @default.
• W268446039 cites W2065631558 @default.
• W268446039 cites W2072996837 @default.
• W268446039 cites W2075603878 @default.
• W268446039 cites W2078386170 @default.
• W268446039 cites W2078964661 @default.
• W268446039 cites W2088013666 @default.
• W268446039 cites W2092000556 @default.
• W268446039 cites W2119774260 @default.
• W268446039 cites W2143049545 @default.
• W268446039 cites W2235427389 @default.
• W268446039 cites W2354832715 @default.
• W268446039 cites W2376886275 @default.
• W268446039 cites W2414324521 @default.
• W268446039 doi "https://doi.org/10.4238/2015.may.12.2" @default.
• W268446039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25966274" @default.
• W268446039 hasPublicationYear "2015" @default.
• W268446039 type Work @default.
• W268446039 sameAs 268446039 @default.
• W268446039 citedByCount "27" @default.
• W268446039 countsByYear W2684460392015 @default.
• W268446039 countsByYear W2684460392016 @default.
• W268446039 countsByYear W2684460392017 @default.
• W268446039 countsByYear W2684460392018 @default.
• W268446039 countsByYear W2684460392020 @default.
• W268446039 countsByYear W2684460392021 @default.
• W268446039 countsByYear W2684460392022 @default.
• W268446039 countsByYear W2684460392023 @default.
• W268446039 crossrefType "journal-article" @default.
• W268446039 hasAuthorship W268446039A5006466643 @default.
• W268446039 hasAuthorship W268446039A5024325354 @default.
• W268446039 hasAuthorship W268446039A5032098174 @default.
• W268446039 hasAuthorship W268446039A5040831062 @default.
• W268446039 hasAuthorship W268446039A5061528583 @default.
• W268446039 hasBestOaLocation W2684460391 @default.
• W268446039 hasConcept C105696609 @default.
• W268446039 hasConcept C11960822 @default.
• W268446039 hasConcept C120504264 @default.
• W268446039 hasConcept C1491633281 @default.
• W268446039 hasConcept C153911025 @default.
• W268446039 hasConcept C185592680 @default.
• W268446039 hasConcept C2777781930 @default.
• W268446039 hasConcept C2778437423 @default.
• W268446039 hasConcept C2781252693 @default.
• W268446039 hasConcept C29537977 @default.
• W268446039 hasConcept C50001416 @default.
• W268446039 hasConcept C502942594 @default.
• W268446039 hasConcept C55493867 @default.
• W268446039 hasConcept C62112901 @default.
• W268446039 hasConcept C75217442 @default.
• W268446039 hasConcept C86803240 @default.
• W268446039 hasConcept C95444343 @default.
• W268446039 hasConcept C98274493 @default.
• W268446039 hasConceptScore W268446039C105696609 @default.
• W268446039 hasConceptScore W268446039C11960822 @default.
• W268446039 hasConceptScore W268446039C120504264 @default.
• W268446039 hasConceptScore W268446039C1491633281 @default.
• W268446039 hasConceptScore W268446039C153911025 @default.
• W268446039 hasConceptScore W268446039C185592680 @default.
• W268446039 hasConceptScore W268446039C2777781930 @default.
• W268446039 hasConceptScore W268446039C2778437423 @default.
• W268446039 hasConceptScore W268446039C2781252693 @default.
• W268446039 hasConceptScore W268446039C29537977 @default.
• W268446039 hasConceptScore W268446039C50001416 @default.
• W268446039 hasConceptScore W268446039C502942594 @default.
• W268446039 hasConceptScore W268446039C55493867 @default.
• W268446039 hasConceptScore W268446039C62112901 @default.
• W268446039 hasConceptScore W268446039C75217442 @default.
• W268446039 hasConceptScore W268446039C86803240 @default.

• next